Total Payments
$1,781
2024 Payments
$86.60
Companies
15
Transactions
35
Medicare Patients
297
Medicare Billing
$20,238
Payment Breakdown by Category
Research$1,185 (66.5%)
Food & Beverage$556.32 (31.2%)
Education$39.91 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,185 | 3 | 66.5% |
| Food and Beverage | $556.32 | 30 | 31.2% |
| Education | $39.91 | 2 | 2.2% |
Payments by Type
Research
$1,185
3 transactions
General
$596.23
32 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $898.38 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $312.30 | 2 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $105.76 | 6 | $0 (2022) |
| ABBVIE INC. | $72.88 | 5 | $0 (2022) |
| Hologic, LLC | $68.10 | 4 | $0 (2022) |
| Intuitive Surgical, Inc. | $57.75 | 1 | $0 (2021) |
| PFIZER INC. | $47.90 | 2 | $0 (2022) |
| Evofem Biosciences, Inc. | $47.27 | 2 | $0 (2022) |
| Exeltis, USA Inc. | $42.61 | 2 | $0 (2024) |
| Organon Llc | $29.76 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $86.60 | 5 | Exeltis, USA Inc. ($42.61) |
| 2023 | $43.65 | 3 | Astellas Pharma US Inc ($19.90) |
| 2022 | $156.83 | 8 | ABBVIE INC. ($46.09) |
| 2021 | $153.09 | 6 | Intuitive Surgical, Inc. ($57.75) |
| 2020 | $15.95 | 1 | AbbVie Inc. ($15.95) |
| 2019 | $43.32 | 3 | AMAG Pharmaceuticals, Inc. ($16.87) |
| 2018 | $56.91 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($18.62) |
| 2017 | $1,225 | 5 | Allergan Inc. ($885.00) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/24/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/04/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ETONOGESTREL | ||||||
| 06/04/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: ETONOGESTREL | ||||||
| 01/09/2024 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 06/28/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Biological | ||||||
| 05/08/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: ETONOGESTREL | ||||||
| 02/01/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diagnostics | ||||||
| 12/29/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: WOMENS HEALTH | ||||||
| 11/21/2022 | PFIZER INC. | MYFEMBREE (Drug) | Education | In-kind items and services | $23.04 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 10/13/2022 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: WOMENS HEALTH | ||||||
| 09/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Womens Health | ||||||
| 07/22/2022 | Hologic, LLC | CoolSeal Generator (Device) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Surgical | ||||||
| 05/18/2022 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 04/20/2022 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: WOMENS HEALTH | ||||||
| 03/25/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $23.77 | General |
| 09/14/2021 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $57.75 | General |
| Category: SURGERY | ||||||
| 07/19/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Women's Health | ||||||
| 07/07/2021 | Hologic, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diagnostics | ||||||
| 05/18/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Women's Health | ||||||
| 04/21/2021 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 02/10/2021 | Hologic, LLC | ACESSA PROVU SYSTEM (Device) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Surgical | ||||||
| 02/24/2020 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: WOMENS HEALTH | ||||||
| 07/22/2019 | AMAG Pharmaceuticals, Inc. | MAKENA (Drug) | Education | In-kind items and services | $16.87 | General |
| Category: REDUCTION OF RISK FOR PRETERM BIRTH | ||||||
| 05/01/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, VEHICLE-CONTROLLED STUDY TO EVALUATE SAFETY AND EFFICACY OF THREE DOSES OF ESTRADIOL VAGINAL CAPSULE IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY | Allergan Inc. | $885.00 | 2 |
| Nexplanon Observational Risk Assessment Study NORA | Merck Sharp & Dohme Corporation | $300.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 63 | 78 | $10,606 | $5,247 |
| 2022 | 5 | 77 | 92 | $10,015 | $5,072 |
| 2021 | 6 | 108 | 133 | $13,980 | $6,942 |
| 2020 | 3 | 49 | 56 | $6,455 | $2,978 |
Total Patients
297
Total Services
359
Medicare Billing
$20,238
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 40 | $5,120 | $2,545 | 49.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $2,256 | $1,215 | 53.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,702 | $1,020 | 37.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 12 | 12 | $528.00 | $467.40 | 88.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 27 | $3,456 | $1,732 | 50.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,474 | $1,605 | 46.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 16 | 16 | $704.00 | $625.95 | 88.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 13 | 13 | $689.00 | $564.21 | 81.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 18 | $1,692 | $545.12 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 30 | $3,840 | $2,085 | 54.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 37 | $3,478 | $1,392 | 40.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $3,474 | $1,358 | 39.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 25 | 25 | $1,100 | $988.75 | 89.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 11 | 11 | $1,452 | $589.70 | 40.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 12 | 12 | $636.00 | $528.24 | 83.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 28 | $3,584 | $1,424 | 39.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,123 | $868.05 | 40.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 17 | 17 | $748.00 | $685.77 | 91.7% |
About Dr. John Mckenna, MD
Dr. John Mckenna, MD is a Obstetrics & Gynecology healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164429742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Mckenna, MD has received a total of $1,781 in payments from pharmaceutical and medical device companies, with $86.60 received in 2024. These payments were reported across 35 transactions from 15 companies. The most common payment nature is "" ($1,185).
As a Medicare-enrolled provider, Mckenna has provided services to 297 Medicare beneficiaries, totaling 359 services with total Medicare billing of $20,238. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Spokane, WA
- Active Since 06/28/2005
- Last Updated 05/14/2008
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1164429742
Products in Payments
- ESTRACE CREAM (Drug) $885.00
- IMPLANON (Drug) $300.00
- Mirena (Drug) $58.17
- Da Vinci Surgical System (Device) $57.75
- ORILISSA (Drug) $48.25
- Kyleena (Drug) $47.59
- Phexxi (Drug) $47.27
- SLYND (Drug) $42.61
- NEXPLANON (Drug) $42.06
- APTIMA (Device) $32.48
- ACESSA PROVU SYSTEM (Device) $25.39
- PREMARIN ORALS (Drug) $24.86
- MYFEMBREE (Drug) $23.04
- Twirla (Drug) $19.96
- Veozah (Drug) $19.90
- MAKENA (Drug) $16.87
- CoolSeal Generator (Device) $15.64
- LILETTA (Drug) $13.79
- LO LOESTRIN FE (Drug) $13.38
- Myosure (Device) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Spokane
Dr. Denise Bayuszik, M.d, M.D
Obstetrics & Gynecology — Payments: $49,049
Obstetrics & Gynecology $49,049
Fleur Coulter, Arnp, ARNP
Obstetrics & Gynecology — Payments: $22,849
Obstetrics & Gynecology $22,849
Dr. Robert Olson, M.d, M.D
Obstetrics & Gynecology — Payments: $19,521
Obstetrics & Gynecology $19,521
Kelli Mcentee, M.d, M.D
Obstetrics & Gynecology — Payments: $3,805
Obstetrics & Gynecology $3,805
Molly Dahl, M.d, M.D
Obstetrics & Gynecology — Payments: $3,318
Obstetrics & Gynecology $3,318
Dr. Shelby Apodaca, M.d, M.D
Obstetrics & Gynecology — Payments: $3,067
Obstetrics & Gynecology $3,067